Abstract: Provided with a sheet and a backing sheet for reducing a background luminescence occurs in a fluorescent immunochromatography method. In an immunochromatographic kit having at least a membrane and a backing sheet, wherein a luminescence suppression sheet is provided between the membrane and the backing sheet, and a quantum yield measured by an absolute PL quantum yield spectrometer C11347 manufactured by Hamamatsu Photonics K.K. is 0.40% or less when the luminescence suppression sheet is irradiated with an excitation light having a wavelength of 365 nm.

Abstract: The present invention addresses the problem of providing an endocytosis enhancer comprising associates formed from a fluorescent protein. The fluorescent protein is preferably any one selected from the group consisting of a white fluorescent protein, a red fluorescent protein, a yellow fluorescent protein, a blue fluorescent protein and a green fluorescent protein. The endocytosis enhancer according to the present invention can enhance the cellular uptake of a drug, which is encapsulated in micelles each formed from a fluorescent-protein-supported carbosilane dendrimer, through endocytosis.

Abstract: A combined cycle plant includes: a gas turbine having a compressor, a combustor, and a turbine; a supplementary firing burner configured to raise a temperature of an exhaust gas of the gas turbine; a heat recovery steam generator configured to generate a steam using an exhaust heat of the exhaust gas; a steam turbine configured to be driven by the steam generated by the heat recovery steam generator; and a control device configured to change both an output of the combustor and an output of the supplementary firing burner when an output of the combined cycle plant is to be changed.

Abstract: It is an object of the present invention to provide a fine fluorescent particle, which does not cause concentration quenching and has low ecotoxicity. Specifically, the present invention relates to a fine fluorescent particle containing an AIE-active compound, the particle consisting of a network polymer, wherein the fine fluorescent particle is characterized in that the AIE-active compound is, for example, a compound represented by the following formula (1): wherein E represents silicon or germanium; R1 and R2, which are the same or different, each represent a hydrocarbon group containing 1 to 6 carbon atoms, or a substituted or unsubstituted phenyl group; and R3, R4, R5 and R6, which are the same or different, each represent a substituted or unsubstituted phenyl group.

Abstract: According to one embodiment, a control system comprises a plurality of devices and a controller. The controller stores first information representing a linkage of a plurality of functions that realize a single process and second information representing a correspondence between the devices and the functions, and controls the devices based on the first information and the second information to realize the single process.

Abstract: The present invention relates to a targeting-type capsule for drug delivery systems. The present invention addresses the problem of providing a capsule for drug delivery systems by utilizing the reactivity of a thiol with an alkyl halide, wherein the capsule comprises a silole-containing carbosilane dendrimer and a labeling protein containing a target recognition site (e.g., green fluorescent protein), can include a biological polymer or another molecule therein, and can deliver the biological polymer or the like selectively into a target cell.

Abstract: The object of the present invention is to provide an aggregatable carrier material for drug delivery system and a micelle formed thereof. The present invention provides an aggregatable carrier material for drug delivery system, which is formed by utilizing the reaction between thiol group and alkyl halide. It is formed by using carbosilane dendrimers containing silole and labeled proteins such as green fluorescent protein in aqueous solvent or in mixed solvent of the aqueous solvent and organic solvent. The micelle composed of the material may incorporate compounds having a variety of molecular weight and biopolymers in the aqueous solvent.

Abstract: The present invention is related to a targeted type shell for drug delivery system. The object of the present invention is to provide the targeted type shell for DDS, which comprises a carbosilane dendrimer containing a silole produced by which is formed by utilizing the reaction between thiol group and alkyl halide, and a targeted protein containing a labeled proteins such as green fluorescent protein with a target recognition site. The shell may incorporate compounds having a variety of molecular weight and biopolymers, and selectively deliver them into targeted cells.

Abstract: To provide a combined cycle plant, a control device thereof, and a steam turbine startup method that are aimed at improving the operability of a combined cycle plant by allowing a quick change of the output. A combined cycle plant is provided with: a gas turbine having a compressor, a combustor, and a turbine; a supplementary firing burner that raises the temperature of exhaust gas of the gas turbine; a heat recovery steam generator that generates steam using exhaust heat of the exhaust gas; a steam turbine that is driven by steam generated by the heat recovery steam generator; and a control device that changes both an output of the combustor and an output of the supplementary firing burner when an output of the combined cycle plant is to be changed.

Abstract: The present invention addresses the problem of providing an endocytosis enhancer comprising associates formed from a fluorescent protein. The fluorescent protein is preferably any one selected from the group consisting of a white fluorescent protein, a red fluorescent protein, a yellow fluorescent protein, a blue fluorescent protein and a green fluorescent protein. The endocytosis enhancer according to the present invention can enhance the cellular uptake of a drug, which is encapsulated in micelles each formed from a fluorescent-protein-supported carbosilane dendrimer, through endocytosis.

Abstract: It is an object of the present invention to provide a fine fluorescent particle, which does not cause concentration quenching and has low ecotoxicity. Specifically, the present invention relates to a fine fluorescent particle containing an AIE-active compound, the particle consisting of a network polymer, wherein the fine fluorescent particle is characterized in that the AIE-active compound is, for example, a compound represented by the following formula (1): wherein E represents silicon or germanium; R1 and R2, which are the same or different, each represent a hydrocarbon group containing 1 to 6 carbon atoms, or a substituted or unsubstituted phenyl group; and R3, R4, R5 and R6, which are the same or different, each represent a substituted or unsubstituted phenyl group.

Abstract: The present invention relates to a targeting-type capsule for drug delivery systems. The present invention addresses the problem of providing a capsule for drug delivery systems by utilizing the reactivity of a thiol with an alkyl halide, wherein the capsule comprises a silole-containing carbosilane dendrimer and a labeling protein containing a target recognition site (e.g., green fluorescent protein), can include a biological polymer or another molecule therein, and can deliver the biological polymer or the like selectively into a target cell.

Abstract: The present invention is related to a targeted type shell for drug delivery system. The object of the present invention is to provide the targeted type shell for DDS, which comprises a carbosilane dendrimer containing a silole produced by which is formed by utilizing the reaction between thiol group and alkyl halide, and a targeted protein containing a labeled proteins such as green fluorescent protein with a target recognition site. The shell may incorporate compounds having a variety of molecular weight and biopolymers, and selectively deliver them into targeted cells.

Abstract: To provide a combined cycle plant, a control device thereof, and a steam turbine startup method that are aimed at improving the operability of a combined cycle plant by allowing a quick change of the output. A combined cycle plant is provided with: a gas turbine having a compressor, a combustor, and a turbine; a supplementary firing burner that raises the temperature of exhaust gas of the gas turbine; a heat recovery steam generator that generates steam using exhaust heat of the exhaust gas; a steam turbine that is driven by steam generated by the heat recovery steam generator; and a control device that changes both an output of the combustor and an output of the supplementary firing burner when an output of the combined cycle plant is to be changed.

Abstract: The object of the present invention is to provide an aggregatable carrier material for drug delivery system and a micelle formed thereof. The present invention provides an aggregatable carrier material for drug delivery system, which is formed by utilizing the reaction between thiol group and alkyl halide. It is formed by using carbosilane dendrimers containing silole and labeled proteins such as green fluorescent protein in aqueous solvent or in mixed solvent of the aqueous solvent and organic solvent. The micelle composed of the material may incorporate compounds having a variety of molecular weight and biopolymers in the aqueous solvent.

Abstract: According to one embodiment, an information processing device includes a receiving section configured to receive a trigger signal from a device connected thereto, a verifying section configured to verify the trigger signal when the receiving section receives the trigger signal, and an activating section configured to activate the system when the verification of the trigger signal is successfully made by the verifying section.

Abstract: According to one embodiment, an information processing apparatus includes an input to input a password, a biological authentication device including a storage unit for storing biological information and identification information, and an authentication controller. The authentication controller sets and holds identification information to be stored in the storage unit of the biological authentication device, and permits a password input using the input to be substituted by authentication using the biological authentication device when the identification information held by itself and the identification information stored in the storage unit of the biological authentication device match.

Abstract: According to one embodiment, if start-up of an application is abnormal after starting up the application, the information processing apparatus reports the fact to the basic input/output system (BIOS), and the BIOS locks a system.

Abstract: According to one embodiment, an information processing apparatus includes an input module to input a password, a biological authentication device including a storage unit for storing biological information and identification information, and an authentication control module which sets and holds identification information to be stored in the storage unit of the biological authentication device, and permits a password input using the input module to be substituted by authentication using the biological authentication device when the identification information held by itself and the identification information stored in the storage unit of the biological authentication device match.

Abstract: According to one embodiment, if start-up of an application is abnormal after starting up the application, the information processing apparatus reports the fact to the basic input/output system (BIOS), and the BIOS locks a system.